HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mamta Puraswani Selected Research

Mamta Puraswani Research Topics

Disease

5Atypical Hemolytic Uremic Syndrome
01/2024 - 04/2018
3Nephrotic Syndrome (Syndrome, Nephrotic)
01/2019 - 03/2014
2Hemolytic-Uremic Syndrome
01/2024 - 04/2018
2Genetic Predisposition to Disease (Genetic Predisposition)
06/2018 - 02/2018
1Infections
12/2023
1Mucormycosis
12/2022
1Bacterial Infections (Bacterial Infection)
12/2022
1Coinfection
12/2022
1Proteinuria
03/2014
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
03/2014
1Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
03/2014

Drug/Important Bio-Agent (IBA)

3Complement Factor H (Factor H)IBA
01/2024 - 01/2019
2Complement System Proteins (Complement)IBA
01/2023 - 06/2018
2AutoantibodiesIBA
01/2023 - 02/2018
1eculizumabFDA Link
01/2024
1Colistin (Coly-Mycin)FDA Link
12/2023
1ProcalcitoninIBA
12/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2019
1Levamisole (Decaris)FDA Link
01/2019
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
01/2019
1Rituximab (Mabthera)FDA Link
10/2018
1Monoclonal AntibodiesIBA
10/2018
1Membrane Cofactor ProteinIBA
04/2018
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
03/2014
1CreatinineIBA
03/2014
1SteroidsIBA
03/2014

Therapy/Procedure

2Plasma Exchange
01/2024 - 04/2018
2Therapeutics
01/2023 - 01/2019
1Length of Stay
12/2022